Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Code:
NCT01631617
Conditions
Eczema
Dermatitis
Skin Diseases, Genetic
Dermatitis, Atopic
Skin Diseases
Eligibility Criteria
Sex: All
Age: 2 - 50
Healthy Volunteers: Accepted
Interventions
Trimethoprim/sulfamethoxazole (TMP/SMZ)
Cephalexin
Doxycycline
Sodium hypochlorite
Placebo capsules
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on 2025-05-29.